LSL Pharma Group

LSL Pharma Group Current Liabilities

The Current Liabilities of LSL Pharma Group (LSL.V) as of Nov 1, 2026 is 4.46 M CAD. In the previous year, Current Liabilities was 8.96 M CAD — a change of -50.26% (lower).

Current Liabilities

4.46 MCAD

YoY

-50.26%

Last updated:

Current Liabilities of LSL Pharma Group is 2025 4.46 M CAD. Current Liabilities of LSL Pharma Group was 2024 8.96 M CAD. It decreases by -50.26% lower compared to the previous year.

The LSL Pharma Group Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2011
40,000.00 CAD
Jan 1, 2012
80,000.00 CAD
Jan 1, 2020
3.65 M CAD
Jan 1, 2021
190,000.00 CAD
Jan 1, 2022
280,000.00 CAD
Jan 1, 2023
10.92 M CAD
Jan 1, 2024
8.96 M CAD
Jan 1, 2025
4.46 M CAD
The LSL Pharma Group Current Liabilities history
YEARCurrent LiabilitiesYoY
4.46 MCAD-50.26%
8.96 MCAD-17.89%
10.92 MCAD+3,798.57%
280,000.00CAD+47.37%
190,000.00CAD-94.79%
3.65 MCAD+4,456.77%
80,000.00CAD+100.00%
40,000.00CAD+300.00%
10,000.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

LSL Pharma Group Stock analysis

What does LSL Pharma Group do? LSL Pharma Group, Inc. generates revenue through the development, manufacturing, and distribution of natural health products and dietary supplements in solid dosage forms, as well as sterile ophthalmic pharmaceutical products. The company operates as a pharmaceutical entity specializing in these specific therapeutic and wellness categories to meet market demand. The firm utilizes its subsidiaries, including Steri-Med Pharma Inc., LSL Laboratory Inc., and Groupe Immobilier LSL inc., to support its core operations. These entities facilitate the company's ability to produce and distribute its specialized pharmaceutical and supplement offerings effectively within its operational framework. LSL Pharma Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LSL Pharma Group stock

Current Liabilities of LSL Pharma Group is 4.46 M CAD in 2025.

Current Liabilities of LSL Pharma Group changed from 8.96 M CAD to 4.46 M CAD, representing a -50.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities LSL Pharma Group since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's LSL Pharma Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — LSL Pharma Group

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — LSL Pharma Group